Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic CancerJulien Dilly, Brian M. Wolpin, Andrew J. Aguirre et al.|Cancer Discovery|2024Cited by 234
Cross-species identification of genomic drivers of squamous cell carcinoma development across preneoplastic intermediatesVida Chitsazzadeh, Kenneth Y. Tsai, Cristian Coarfa et al.|Nature Communications|2016Cited by 159
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosaRaymond J. Cho, Andrew P. South, Ludmil B. Alexandrov et al.|Science Translational Medicine|2018Cited by 132
Nuclear Receptor Corepressor 1 Expression and Output Declines with Prostate Cancer ProgressionSandra M. Lopez, Irina U. Agoulnik, Alexander I. Agoulnik et al.|Clinical Cancer Research|2016Cited by 25
Supplementary Figures from Nuclear Receptor Corepressor 1 Expression and Output Declines with Prostate Cancer ProgressionSandra M. Lopez, Irina U. Agoulnik, Alexander I. Agoulnik et al.|Unknown|2023Cited by 0